Identification of Salmonella enterica serovar Typhi genotypes by use of rapid multiplex ligation-dependent probe amplification. by Pham Thanh, Duy et al.
Pham Thanh, D; Tran Vu Thieu, N; Tran Thuy, C; Lodn, M; Tuin, K;
Campbell, JI; Van Minh Hoang, N; Voong Vinh, P; Farrar, JJ; Holt,
KE; Dougan, G; Baker, S (2013) Identification of Salmonella enter-
ica Serovar Typhi Genotypes by Use of Rapid Multiplex Ligation-
Dependent Probe Amplification. Journal of clinical microbiology, 51
(9). pp. 2950-8. ISSN 0095-1137 DOI: 10.1128/JCM.01010-13
Downloaded from: http://researchonline.lshtm.ac.uk/1300533/
DOI: 10.1128/JCM.01010-13
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
Identification of Salmonella enterica Serovar Typhi Genotypes by Use
of Rapid Multiplex Ligation-Dependent Probe Amplification
Duy Pham Thanh,a Nga Tran Vu Thieu,a Chau Tran Thuy,a Martin Lodén,c Kiki Tuin,c James I. Campbell,a,e Nguyen Van Minh Hoang,a
Phat Voong Vinh,a Jeremy J. Farrar,a,e Kathryn E. Holt,b Gordon Dougan,d Stephen Bakera,e,f
The Hospital for Tropical Diseases, Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnama; Department of
Microbiology and Immunology, The University of Melbourne, Melbourne, Australiab; MRC-Holland, Amsterdam, The Netherlandsc; The Wellcome Trust Sanger Institute,
Hinxton, Cambridge, United Kingdomd; Centre for Tropical Diseases, University of Oxford, Oxford, United Kingdome; The London School of Hygiene and Tropical
Medicine, London, United Kingdomf
Salmonella enterica serovar Typhi, the causative agent of typhoid fever, is highly clonal and genetically conserved, making iso-
late subtyping difficult. We describe a standardized multiplex ligation-dependent probe amplification (MLPA) genotyping
scheme targeting 11 key phylogenetic markers of the S. Typhi genome. TheMLPAmethod demonstrated 90% concordance with
single nucleotide polymorphism (SNP) typing, the gold standard for S. Typhi genotyping, and had the ability to identify isolates
of the H58 haplotype, which is associated with resistance to multiple antimicrobials. Additionally, the assay permitted the detec-
tion of fluoroquinolone resistance-associated mutations in the DNA gyrase-encoding gene gyrA and the topoisomerase gene
parCwith a sensitivity of 100%. TheMLPAmethodology is simple and reliable, providing phylogenetically and phenotypically
relevant genotyping information. This MLPA scheme offers a more-sensitive and interpretable alternative to the nonphyloge-
netic subgrouping methodologies that are currently used in reference and research laboratories in areas where typhoid is
endemic.
Typhoid fever, caused by Salmonella enterica serovar Typhi (S.Typhi), remains a significant cause ofmortality andmorbidity
in many regions of the world (1, 2). S. Typhi is a pathogen that is
exclusive to humans, and this exquisite level of host restriction is
reflected in the genome and population structure of the organism
(3). S. Typhi isolates share an exceptionally high level of genetic
conservation, making informative subtyping for local and inter-
national epidemiology challenging (3). Many methods involving
both phenotypic and genotypic techniques have been developed
to differentiate between S. Typhi isolates. Phage typing was long
considered the standard method for strain subtyping; however,
this technique provides little or no phylogenetic information, is
technically intensive, and is only performed in specialized refer-
ence laboratories (4, 5). Multilocus sequence typing (MLST) can-
not productively be applied to S. Typhi because of its monophy-
letic nature (6). Other molecular techniques, including random
amplified polymorphic DNA PCR (RAPD-PCR), pulsed-field gel
electrophoresis (PFGE), and amplified fragment length polymor-
phisms (AFLP), have some discriminatory power but provide a
limited ability to define absolute phylogenetic and epidemiologi-
cal relationships between isolates (7–9). More recently, genome
sequencing and the identification of single nucleotide polymor-
phisms (SNPs) have provided the first well-defined phylogenetic
framework within which to assign S. Typhi isolates to irrefutable
genotypes that can describe the population (10–13). These studies
revealed that S. Typhi genotypes are globally dispersed but are
increasingly dominated by a single genotype (H58), which com-
monly displays resistance to multiple antimicrobials. H58 isolates
frequently harbor multidrug-resistant incompatibility group HI1
(IncHI1) plasmids, as well as mutations in the gyrA gene, which
confer reduced susceptibility to fluoroquinolones (7, 13).
While SNP detection and genome sequencing are the gold
standards for S. Typhi subtyping (7, 10, 11), these methodologies
remain in the domain of research institutions, which have the
facilities, expertise, and infrastructure to support these activities.
Therefore, there is a translation gap that stands in the way of
utilizing genomic information for subtyping S. Typhi in endemic
locations. To address this, we have developed a simple transport-
able method for genotyping S. Typhi that can be performed in a
laboratory with only modest molecular biology capabilities.
S. Typhi genomes harbor several genomic insertions and dele-
tions (indels) that we hypothesize to be phylogenetically informa-
tive andmay be used asmarkers for inferring genotypes within the
S. Typhi population (12). Therefore, we predicted that by assaying
for selected indels in the S. Typhi genome, we can infer genotype,
rather than having to perform genome-wide SNP analysis or ge-
nome sequencing.Multiplex ligation-dependent probe amplifica-
tion (MLPA) is a PCR method that permits multiple DNA se-
quence targets to be amplified with a single primer pair (14). The
ability of the method to detect DNA signatures, as well as individ-
ual SNPs, increases its potential utility and provides a system that
can be globally standardized. We have designed, validated, and
used an MLPA assay to genotype S. Typhi isolates and investigate
the molecular epidemiology of typhoid in Asia. Our data show
that S. Typhi MLPA is simple, robust, and comparable to the gold
standard of SNP typing, permitting the identification of themajor
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genotypes, as well as mutations that are associated with reduced
susceptibility to fluoroquinolones. The method presented here
can be applied to other organisms and represents an alternative to
MLST, PFGE, genome sequencing, and serotyping when the abil-
ity to perform these methods or the methods themselves are lim-
ited.
MATERIALS AND METHODS
Bacterial isolates. A total of 227 Salmonella isolates (217 S. Typhi and 10
S. enterica serovar Paratyphi A) were used in this study (see Table S1 in the
supplemental material). All bacterial isolates originated from previous
investigations conducted in southern Vietnam between 1993 and 2005 or
across seven other Asian countries between 2002 and 2004, as previously
described (15). Nineteen S. Typhi isolates that were previously whole-
genome sequenced were used as controls for SNP typing and validation of
the MLPA method; these isolates were provided by the Wellcome Trust
Sanger Institute (United Kingdom) collection and are additionally de-
scribed in Table S1 in the supplemental material (12). The 10 S. Paratyphi
A isolates originated from India and were included as an out-group for
SNP genotyping and MLPA analysis.
Microbiological methods. All bacterial isolates were identified by
standard biochemical tests and agglutination with Salmonella-specific an-
tiserum (Murex Diagnostics, Dartford, United Kingdom). Antimicrobial
susceptibilities were tested at the time of isolation by the modified Bauer-
Kirby disk diffusion method, as recommended by the CLSI guidelines
(16). The antimicrobial disks tested were chloramphenicol (CHL) (30
g), ampicillin (AMP) (10 g), trimethoprim-sulfamethoxazole (SXT)
(1.25/23.75 g), ofloxacin (OFX) (5 g), ciprofloxacin (CIP) (5 g), and
nalidixic acid (NAL) (30g).MICswere determined by Etest against CIP,
NAL, and OFX, according to the manufacturer’s recommendations (AB
Biodisk, Sweden).Mueller-Hinton agar and antimicrobial diskswere pur-
chased from UniPath, Basingstoke, United Kingdom. Escherichia coli
strain ATCC 25922 and Staphylococcus aureus strain ATCC 25923 were
used as control strains for these assays. The results were interpreted
according to current CLSI guidelines (16). An isolate was defined as
multidrug resistant (MDR) if it was resistant to chloramphenicol, tri-
methoprim-sulfamethoxazole, and ampicillin.
PCRamplificationandDNAsequencing.DNAwas extracted fromall
S. Typhi isolates using theWizard genomicDNA extraction kit (Promega,
Fitchburg, WI). Oligonucleotide primers for the amplification of the
quinolone resistance-determining regions (QRDRs) in the gyrA and parC
genes in S. Typhi were as described in Table 1. PCRs were performed
under the following conditions: 92°C for 45 s, 55°Cor 62°C (depending on
the primer pair) for 45 s, and 74°C for 1 min, for 30 cycles, followed by a
final extension step at 74°C for 2 min. DNA sequencing reactions were
performed using the CEQ Dye Terminator cycle sequencing (DTCS)
quick start kit (Beckman Coulter) and were sequenced using a CEQ 8000
capillary sequencer (Beckman Coulter). All resulting DNA sequences
were analyzed using the CEQuence investigator CEQ2000XL (Beckman
Coulter) before verification, alignment, and editing in BioEdit software
(http://www.mbio.ncsu.edu/BioEdit/bioedit. html). BLASTn at theNCBI
was used to compare all resulting gyrA and parC sequences to those of
global S. Typhi isolates. PCR amplification was used to confirm the inser-
tion or deletion of the target sequence across all S. Typhi isolates prior to
probe design and MLPA analysis; the primers used are shown in Table 1.
PCRs were performed using the following conditions: 92°C for 45 s, 55 to
62°C for 45 s, and 74°C for 45 s, for 30 cycles, followed by a final extension
step at 74°C for 2 min (Table 1).
MLPA.AllMLPA reagents weremanufactured and supplied byMRC-
Holland (Amsterdam, The Netherlands). Sixteen S. Typhi-specificMLPA
probes were designed according to themanufacturer’s recommendations.
The probes are described in Table 2 and target 11 S. Typhi indels (B, Q, A,
K, E, F, S, C, H, N, and D) (Fig. 1). MLPA was performed according to a
standard protocol developed by MRC-Holland, as previously described
(14). Briefly, S. Typhi genomic DNA was diluted with Tris-EDTA (TE)
buffer to final volume of 5l (50 to 200 ng) and heated at 98°C for 10min
TABLE 1 Conventional PCR primers targeting S. Typhi indels and SNPs
Primer Primer sequence (5= to 3=) Targeta Annealing temp (°C) Amplification size (bp)
indelA_F AGCGATGTGATGATCAGGATT Indel A 55 418
indelA_R AATGGCGTGTTCAGTGGATT
indelB_F TCCGTCTCTTTCTCCAGC Indel B 55 368
indelB_R AATTGATGCTGCTGCTGGACG
indelC_F ACGGGTGAAATACTCGAACG Indel C 58 783
indelC_R CACCAAGCAGATTGTTCAGG
indelD_F CGCTATTTTTTCCGCCCATGC Indel D 60 1,451
indelD_R TAATAACATCGGCGTGCCG
indelE_F CCGTCGCCAAAGTGACGC Indel E 55 993
indelE_R CCGTTGAATCGGAAGTAATAATCG
indelF_F AAGCAAATGCTTAGCACCAC Indel F 55 180
indelF_R CAATGCATAAAGTTAATTTAATCAGGA
indelK_F ATGGGTGAGCGCCTCTTTGG Indel K 55 155
indelK_R GACTGGCTGGACATTTTGTG
indelN_F ATGTTTCATGTGTGGGTAGGGTTGCC Indel N 58 720
indelN_R AAGAATGCCCATTGAGCGG
indelQ_F CAACACCCGTGCGGACGAT Indel Q 60 841
indelQ_R AGCTTACTTCCGGCTCCGAC
indelS_F TTGGTGATAAAATTGGCTCGGG Indel S 60 1,116
indelS_R AAAGAATGGAAACCAGAGTTTCC
indelH_F GTGGCAAAACAACGCATCG Indel H 62 6,560
indelH_R CGGTGGAGTTAGTGATGCTGA
GYRA/P1 TGTCCGAGATGGCCTGAAGC gyrA 55 347
GYRA/P2 TACCGTCATAAGTTATCCACG
StmparC1 CTATGCGATGTCAGAGCTGG parC 62 270
StmparC2 TAACAGCAGCTCGGCGTATT
a Indel sites correspond to those shown in Fig. 1.
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in a thermocycler (Bio-Rad). After denaturation, theDNAwas hybridized
with MLPA reagents at 60°C. After overnight incubation, ligation was
performed at 54°C for 15min, followed by 98°C for 5min. Tenmicroliters
of the ligation mixture was added to 30 l of PCR buffer. After equilibra-
tion at 60°C, 10 l of SALSA PCR master mix, containing the labeled
forward primer 5=-FAM-GGGTTCCCTAAGGGTTGGA-3= (FAM,
6-carboxylfluorescein) and the unlabeled reverse primer 5=-GTGCCAGC
AAGATCCAATCTAGA-3=, was added. PCR amplification was per-
formed using 35 cycles of 95°C for 30 s, 60°C for 30 s, and 72°C for 45 s,
followed by 72°C for 20 min. The resulting MLPA amplicons were exam-
ined by agarose gel (3%) electrophoresis and by fragment analysis using
an ABI 3130xl capillary electrophoresis system (Applied Biosystems). For
fragment analysis, 0.5 l of PCR amplicon was mixed with 9.25 l of
Hi-Di formamide and 0.25 l 500 LIZ size standard (GeneScan; Applied
Biosystems). The mixture was incubated for 3 min at 95°C, chilled for 10
min, and analyzed. The resulting fragment analysis data were analyzed
using GeneMapper v4.0 (Applied Biosystems). Data were analyzed using
BioNumerics (Applied Maths, Belgium), and phylogenetic trees were
drawn using Dendroscope v2.3.
Single nucleotide polymorphism genotyping. A cross-sectional sub-
set of 73 S. Typhi isolates was arbitrarily selected to encompass a range
of locations, antimicrobial resistance patterns, studies in Vietnam, and
dates of isolation for gold-standard SNP genotyping using the Illumina
GoldenGate platform (see Table S1 in the supplemental material). DNA
was extracted from all S. Typhi isolates as described above, and concen-
trations were assessed using the Quant-iT kit (Invitrogen, Carlsbad, CA)
prior to SNP typing. The chromosomal haplotype of S. Typhi isolates was
determined based on the SNPs present at 1,485 chromosomal loci identi-
fied previously from genome-wide surveys (12, 17). All loci were interro-
gated using a GoldenGate (Illumina) custom assay according to the man-
ufacturer’s standard protocols, as described previously (10, 11, 18, 19).
SNP calls were generated from raw fluorescence signal data by clustering
with a modified version of Illuminus, as described previously (10, 11, 18,
19). SNP alleles were concatenated to generate a multiple-sequence align-
ment; maximum likelihood phylogenetic trees were fitted to each align-
ment using RAxML with a general time reversible plus gamma (GTR)
model and 1,000 bootstraps as previously described (11, 20).
RESULTS
Development of MLPA to detect phylogenetically informative
indels in the S. Typhi genome. Data gleaned from genome se-
quencing predicted that the presence or absence of certain indels
within the S. Typhi chromosomemight be phylogenetically infor-
mative markers for assigning S. Typhi isolates to the genotype
groups originally defined by SNP analysis (12). Consequently,
conventional PCR assays were designed to independently detect
11 of these previously described indels (12). Each target (A, B, C,
D, E, F, H, K, N, Q, and S) was selected to represent one of the
main branches of the S. Typhi phylogenetic tree, and where two
indels were present on one branch, one was selected to avoid re-
dundancy (Table 1, Fig. 1).
TABLE 2 MLPA probe targets and sequences
MLPA target Fragment/amplicon length (bp) MLPA probe sequencea
parCb 130 TCAATACGACTCTAGATTAGACACCATGGCTTCATAGCAGGCGA
TGTCGCCATGCGGGTGATACTTACCTATTATGCTGAGC
Indel B 139 TTCCGGTCAGACTTGGACGCAAAATACAGGTA
CGAAAGGCCAGCTCGTGAAAATCCATAGAGGGGCT
Indel Q 158 TTATGGACGCTGGTGCAGCAGGAG
CCCTCCCATCCGTTAATTGTTAGTACCACGCTGAACACCG
Indel A 175 TTTTAGTCCATCACGCGCTTCAACATCCGTTC
TATCAGGATGTTGAAAAAGTGGTGCGCATTAATCCACTGAACAC
Indel K 204 TCGACTGGCTGGACATTTTGTGGTTC
TCTGCCGATGCGCTGGAGCAGCTTTGTGATGCGCT
gyrAb,c 238 CCAGCGAGAATGGCTGCGCCATACGAACGA
AATCGCCGTGGGGATGGTATTTACCGATTACGTCACCAACGAC
Indel E 252 GGAACATGGCGATATCAAATCCATCAATG
AAAGCGTCCAGTCCCTGTTTGATGCTCAGTCCCTG
aroC 267 GACAACAACGATAACGGAGCCGTGATGGCA
GGAAACACAATTGGACAACTCTTTCGCGTAACCACTTTCG
Indel S 275 GCTCTCTGGCTTTTTGAACACAGAAATGG
TCGAGTGAAATCAGCTTTGACTTAGCCCTTTTATAAAGCCTTGCGGC
Indel F 308 GCAGTCAGATTTGAACGTCCGGCATAA
AAATAAGTGCTATTAAGCTCTTCAACTGTATCCATACTCTAATTTCCTG
Indel C 362 CTAAAGCGTCGTTGATAATGGTGTAACGGT
GAACTGTCACAGGTCGTGGCGTTATCTTCGATAAACTTCACCT
fliC 374 CTGTTGACCCAGAATAACCTGAACAAATCC
CAGTCCGCACTGGGCACTGCTATCGAGCGTTTGT
Indel H 414 CTTGCTTTACCGAGCAGCATATTCTTTCCGCT
ATGACCGTTCAGTATTTGCAGAAGAAAGGCTTTCAGGTTCAGCC
ssaV 429 CCTGATTCCCTCACCTAACCATGAAC
GCATTGCGACTCCAGAAATTTTATTTGTCGATGATGTAATCGTAACC
Indel N 465 CCAGCACAGGCGTATTATCGCTAACACGCT
CACCAACATAGTCGATTTCATGCCAGTAAACTATTGGTAGCCTGGT
Indel D 494 CCTGGTCAAGCGTTAACTTTATTACTGCCCAT
GACGGCTTCACGCTGAACGATCTGGTGTCTTATAACGA
a Probes comprise left and right hybridization sequences.
b Probe contains a nucleotide to detect a specific SNP in the QRDR region (boldface and underlined).
c gyrA probe requires a spanning oligonucleotide to detect mutations at codons 83 and 87 (TGGTGTCATACACTGCGA).
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Conventional PCR amplification, detecting indels at the 11 tar-
get loci, was performed on DNA extracted from the 19 S. Typhi
isolates that had been whole-genome sequenced (12) (Table 3).
The PCR amplification results (PCR/indel and PCR/indel)
corresponded precisely with the genome sequencing data, con-
firming the phylogenetic potential of these 11 indel targets in the
selected isolates.
AnMLPA probe set was designed to detect the same 11 indels,
as well as SNPs in the gyrA and parC genes and sequences within
the conserved S. Typhi genes aroC, ssaV, and fliC to serve as con-
trols for hybridization, amplification, and detection. The probe
sequences and the predicted amplicon length for each target are
shown in Table 2. The gyrA and parC probes were designed to
detect SNPs associated with reduced susceptibility to fluoro-
quinolones within the QRDRs. Although several mutations have
been identified at gyrA codon 83, the most common mutation
associatedwith fluoroquinolone resistance (TCC to TTC) (15, 21)
changes serine to phenylalanine (S83F); thus, the gyrA probe was
designed to target this mutation. Additionally, a spanning probe
was added to differentiate mutations at codons 83 and 87 within
gyrA; it was designed so that a wild-type allele would not yield a
detectable DNA fragment and so other (non-S83F) mutations at
codons 83 and 87 would generate a product of decreased intensity
in comparison to any product yielded from the S83F mutation.
The parC probe was designed to detect the most common fluoro-
quinolone resistancemutation (AGC toATC), which changes ser-
ine to isoleucine at codon 80, and to yield a product only when an
S. Typhi isolate contained the S80I mutation (15, 21). The indel
type was inferred by the absence of amplification or of peaks fol-
lowing fragment analysis (Fig. 2).
ValidationofMLPA forS. Typhi genotyping anddetectionof
gyrA and parCmutations.MLPAwas performed usingDNApre-
pared from 19 global S. Typhi isolates that were previously whole-
genome sequenced (Table 3) (12). Analysis of the DNA fragments
FIG 1 Indels in the SalmonellaTyphi genome. (a) Phylogenetic tree of S. Typhi derived fromSNPdata, adapted fromHolt et al. (12). The broken linewith a black circle
designates the ancestral root; allmajorhaplotypes arehighlighted (e.g.,H58).Capitalized colored letters represent 17different indels, thepositionof the indels on the tree
indicates the branch with which they are associated, and the asterisks highlight the 11 indels selected for MLPA. (b) Genomic map of S. Typhi strain CT18 from 1 to
4,800,000 bp (coordinates shown). Highlighted are the genomic positions and the strand of the 17 indels and the aroC, ssaV, fliC, gyrA, and parC genes. In the center of
the map is a description of the 17 indels (A to S), showing the genomic coordinates (with respect to S. Typhi CT18) and the affected coding sequence(s).
TABLE 3 Comparison of S. Typhi MLPA indel genotyping and genome
sequencing
S. Typhi
isolatea
Location of
isolation Haplotypea
Predicted indel pattern
as determined by:
Sequencinga MLPA
E98-2068 Bangladesh H42 KB KB
CT18 Vietnam H1 KB KB
J185SM Indonesia H85 KB KB
404ty Indonesia H59 KB KB
E03-4983 Indonesia H59 KBA KBA
AG3 Vietnam H58 KBCE KBCE
8(04)-N Vietnam H58 KBCE KBCE
E02-2759 India H58 KBCE KBCE
E03-9804 India H58 KBCE KBCE
ISP-03-07467 Morocco H58 KBCE KBCE
ISP-04-06979 Central Africa H58 KBCE KBCE
150(98)S Vietnam H63 KBCES KBCES
E98-0664 Kenya H55 K K
M223 Unknown H8 K K
Ty2 Russia H10 KBCS KBCS
E01-6750 Senegal H52 KBCS KBCS
E98-3139 Mexico H50 KF KF
E00-7866 Morocco H46 Q Q
E02-1180 India H45 D D
a See Holt et al. (12).
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FIG 2 Salmonella TyphiMLPA indel typing. (a) Fragment analysis generated byMLPA of S. Typhi isolate 113 fromVietnam, demonstrating a KB (H1) indel pattern
S. Typhi byMLPA (KBpeaks aremissing, indicated by broken lines). Each peak correspondswith the fluorescence intensity of amplicons targeting specific loci (labeled
at the topof eachpeak), including a large peak at 238 bp associatedwith a single gyrAmutation at codon83. (b) Fragment analysis generated byMLPAof S. Typhi isolate
9019 fromVietnam, demonstrating a KBCE (H58) indel pattern byMLPA (KBCE peaks aremissing, indicated by broken lines). This isolate has two gyrAmutations at
codons 83 and 87 and a parCmutation, as determined by a diminished peak at 238 bp and large peak at 130 bp, respectively. (c) Representative fragment analysis of S.
TyphiMLPAampliconsby agarose gel electrophoresis. Fourteenbands are visible andcorrespondwith thepredictedMLPAamplicon lengths shown inTable 2. LaneM,
100-bpmarker; lane 1,S. Typhi 113/Vietnam(panel a)KB (gyrAmutation); lane 2,S. TyphiA763/India-KBCEN(gyrAmutation); lane 3,S. TyphiTY8339/Vietnam-
KBC (gyrAmutation); lane 4, S. Typhi DOMIC14/China-ancestral (gyrAmutation); lane 5, S. Typhi DOMIC43/China-ancestral (gyrAmutation); lane 6, S. Typhi
TY7045/Vietnam-KBCE (gyrAmutation); lane 7, S. Typhi J348BM/Indonesia-KBC (gyrAmutation); lane 8, S. Typhi AS3357/Bangladesh-KBC (gyrAmutation);
lane 9, S. Typhi DOMI40/China-KS (gyrAmutation); lane 10, DOMI38/China-KS (gyrAmutation).
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generated from these PCR amplifications demonstrated that all
probes, including the controls, performed as anticipated, as they
produced measurable and reproducible amplicons of the pre-
dicted sizes. Representative examples of the resulting DNA frag-
ment analysis and gel electrophoresis are shown in Fig. 2. Notably,
the probes targeting the gyrA and parC mutations were able to
distinguish between isolates with and without mutations in the
QRDR. Figure 2 shows that the parC amplicon was detectable in
isolates with a parC mutation, and a diminished gyrA signal was
visible in isolates with a mutation at codons 83 and 87. The indel
and QRDR patterns of the S. Typhi isolates yielded by MLPA
corresponded precisely with the indel patterns and the gyrA and
parCmutations anticipated from both the genome sequences and
conventional PCR (Table 3).
Next, 73 S. Typhi isolates of undetermined genotype fromBan-
gladesh, China, India, Indonesia, Laos, Pakistan, andVietnamand
10 S. Paratyphi A isolates from India (as a control) were typed by
detecting SNP variations at 1,485 previously identified loci across
the S. Typhi genome using a custom GoldenGate assay (see Table
S2 in the supplemental material). These data were used to deter-
mine a phylogenetic tree, which subdivided the 73 S. Typhi iso-
lates into six main genotype groups, broadly corresponding to
those previously defined as H1, H42, H50, H52, H58, and H59
(Fig. 1 and 3) (3, 12). Approximately three-quarters (54/73) of the
genotyped S. Typhi isolates belonged to theH58 genotype, includ-
ing isolates originating from Bangladesh, India, Laos, Pakistan,
and Vietnam. As predicted, the 10 S. Paratyphi A isolates fell into
the ancestral group of S. Typhi via SNP typing, i.e., were ancestral
for all SNPs, as all mutations were S. Typhi specific (data not
shown).
MLPA was then performed on the same 73 S. Typhi isolates
(Fig. 3). The H58 complex has a predicted indel pattern of KBCE
and all 54 of the H58 (as determined by SNP typing) S. Typhi
isolates produced this pattern (Fig. 3). The MLPA indel patterns
were also consistent with the SNP genotypes in all of the H1 (KB),
H42 (KB), and H59 (KB) isolates (9/9 total). The five isolates
belonging to H52 (predicted indel pattern KBCS) produced 3
KBC, 1 KBCS, and 1 KBCDMLPA pattern. The five H50 S. Typhi
isolates (with a predicted KF indel pattern) produced four K pat-
terns and oneKS pattern. Thus, genotype predictions based on the
detection of MLPA indel patterns matched those predicted from
SNP-based genotype assignments in 66/73 (90.4%) of the S. Typhi
isolates. The 10 S. Paratyphi A isolates produced amplicons for the
aroC,fliC, and ssaV genes andproduced peaks correspondingwith
an indel pattern of SF, which does not correlate with any predicted
S. Typhi genotype (see Table S1 in the supplemental material).
MLPA of S. Typhi from eight Asian countries. Subsequently,
MLPA typing was performed on an additional 144 S. Typhi iso-
lates of undetermined genotype from Vietnam (88 isolates) and
seven other Asian countries. The MLPA results were combined
with data from the 73 S. Typhi isolates typed during validation
(see Tables S1 and S2 in the supplemental material). According to
antimicrobial susceptibility testing, 119/217 (54.8%) isolates were
nalidixic acid resistant (NALR) and 82/217 (37.8%) isolates were
MDR (Table 4), and 71 isolates (32.7%) were both NALR and
MDR (Fig. 4). We also used the gyrA and parC MLPA amplicons
to detect the presence of NALR-conferring mutations and com-
pared these data to the antimicrobial susceptibility results (Table
4, Fig. 4).
We detected 10 different indel patterns in the 217 S. Typhi
isolates (Fig. 4, Table 4). Fifty-nine percent of the isolates (128/
217) produced a KBCE or KBCENMLPA pattern, corresponding
to the H58 genotype (Table 4, Fig. 4). This H58 group included
90% of isolates from Vietnam (79/88), 79% of isolates from India
(23/29), 53% of isolates from Bangladesh (9/17), 39% of isolates
from Pakistan (7/18), 31% of isolates from Laos (6/21), and 29%
FIG 3 Comparison ofMLPA and SNP genotyping for S. Typhi. The phylogenetic tree was determined by detecting SNP variations at 1,485 previously identified
loci across the S. Typhi genomes of 73 isolates using a customGoldenGate assay (see Table S1 in the supplemental material). The resulting tree was used to infer
indel patterns (colored capitalized letters) and their associated branches. Examples of S. Typhi strains at pivotal locations throughout the tree are named, and the
H58 group (KBCE indel pattern), consisting of 54 strains, is highlighted in blue.
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of isolates fromNepal (4/14).We additionally identified 4 isolates
with a KBCES indel pattern, and 41 isolates (18%) with a KB indel
pattern (H42 haplotype) were identified and spanned all eight
Asian countries. Twelve isolates (6%) produced a KBC (H52) in-
del pattern, and 22/217 (10%) isolates produced a K indel pattern.
An additional three indel patterns (KE, KS, and KBCS) were iden-
tified across seven isolates, and two Chinese isolates produced
amplicons for all loci and were deemed to be ancestral.
TABLE 4 MLPA indel genotyping of 217 Asian S. Typhi isolates
MLPA indel patterna
No. of
isolates Country of isolation (no.)
No. with gyrAmutation
detected by MLPA
No. with resistance type
Nalidixic acid Multidrug
KBCE 118 Vietnam (79), Bangladesh (9), India (18), Pakistan
(5), Laos (6), Nepal (1)
93 99 73
KBCEN 10 India (5), Nepal (3), Pakistan (2) 7 10 2
KBCES 4 Vietnam (4) 2 2 3
KB 41 Vietnam (4), Bangladesh (5), India (3), Pakistan (5),
Laos (8), Nepal (8), China (1), Indonesia (7)
3 5 4
KBC 12 Vietnam (1), Bangladesh (1) China (9), Indonesia (1) 0 0 0
KBCS 2 Laos (2) 0 0 0
KBCD 1 Laos (1) 0 0 0
K 22 Bangladesh (1), India (2), Pakistan (6), Nepal (2),
China (1), Indonesia (6), Laos (4)
1 2 0
KS 3 China (3) 0 0 0
KE 2 India (1), Bangladesh (1) 0 1 0
No deletions (ancestral) 2 China (2) 0 0 0
Total isolates 217 106 119 82
a Five S. Paratyphi controls gave an indel pattern of SF and were not included in this table (see Table S1 in the supplemental material).
FIG 4 MLPA indel typing of 217Asian S. Typhi isolates. The phylogenetic treewas determined by detecting SNP variations at 1,485 previously identified loci across the
S.Typhigenomesof73 isolatesusingacustomGoldenGateassay inferring thegenotypeof217AsianS.Typhi isolatesbyMLPA.Thecolor codingand labeling is as shown
inFig. 3.Thenumbersof isolateswitha specific indel typeare shown, color coded, andassociatedwithaheatmapshowing thepresence (red)orabsence (blue)ofaNALR
phenotype, a mutation in the QRDR of the gyrA gene byMLPA, a mutation in the QRDR of the parC gene byMLPA, and anMDR phenotype.
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MLPAdetected 106 isolates with an amplicon consistent with a
mutation in gyrA and two isolates with a mutation in parC and a
double mutation in gyrA; all were confirmed by sequencing (Fig.
4, Table 4). Of the 119 isolates with phenotypic NALR, 106 (90%)
tested positive for a gyrAmutation byMLPA (Table 4). TheMLPA
analysis revealed that the H58 indel patterns KBCE and KBCEN
had an increased proportion of NALR isolates compared to other
indel patterns (H58NALR, non-H58NALR) (P 0.0001, Fisher’s
exact test; see Table 4). Furthermore, the same H58 indel group
had an increased proportion of MDR strains compared to other
indel patterns (H58 MDR versus non-H58 MDR) (P  0.0001,
Fisher’s exact test).
DISCUSSION
Phylogenetically informative subgrouping is vital for understand-
ing the local and regional strain circulations of bacterial patho-
gens. Diagnostic, research, and reference laboratories use a range
of typing methods for recording and reporting bacterial diversity
with a variety of pathogens (22, 23). However, these methods of-
ten lack reproducibility, sensitivity, and phylogenetic relevance
(24). The consequence of these limitations is an inability to per-
form robust epidemiological investigations of circulating bacterial
pathogens. Genomics offers a solution to these limitations, and
DNA sequence-basedmethodologies can be used to improve bac-
terial subtyping (10, 25, 26). However, whole-genome sequencing
is currently too specialized and expensive to be employed in areas
where typhoid is endemic. We aimed to address this and devel-
oped a simple and reproducible S. Typhi subtyping method that
can be performed in locations with limited molecular biology
equipment. The MLPAmethod utilizes a limited number of steps
and can be conducted with a standardized set of reagents and
protocols. The method we developed performs well and can be
made commercially available, depending on the demand within
the enteric fever research community. It is difficult to perform a
direct cost comparison of MLPA and sequencing, as demand im-
pacts the cost of the MLPA kit; however, we estimate a cost in the
realm of $10 to $20 per isolate forMLPA compared to the current
cost of $500 to $1,000 per isolate for next-generation sequencing
(price estimated on 5 to 15 coverage of a whole S. Typhi ge-
nome, using a 454 Junior next-generation sequencer with current
costs in Vietnam; this could be reduced by using commercial se-
quencing facilities).
The MLPA method successfully detected all 11 phylogeneti-
cally informative indels, permitting us to infer a genotype for each.
In our test set of 73 S. Typhi isolates, MLPA indel patterns accu-
rately predicted SNP-based genotype assignments in 90% of the
strains. For the remaining isolates, theMLPA profiles were a com-
bination of indels that were similar, but not identical, to those we
anticipated from SNP genotypes. Our method also permitted the
incorporation of probes targeting the QRDR regions of gyrA and
parC. The ability to detect mutations in gyrA and parC is highly
relevant for epidemiological studies of S. Typhi, as NALR S. Typhi
has been reported in the majority of countries where typhoid is
endemic (15, 19, 21, 27). NALR is a reliablemarker of isolates with
a reduced susceptibility to fluoroquinolones, the most common
group of antimicrobials used to treat typhoid. When treated with
fluoroquinolones, NALR S. Typhi is associated with an extended
fever clearance time, prolonged antimicrobial therapy, and an in-
creased risk of treatment failure (28). Therefore, knowing the
prevalence of gyrA mutations in endemic locations is important
for treatment and is of value to epidemiologists, clinicians, and
those making guidelines for clinical care.
Among the 106 isolates in which NALR mutations were de-
tected by MLPA, all gyrA and parC mutations were confirmed by
direct PCR amplicon sequencing, indicating 100% specificity for
the detection of mutations in these genes using MLPA. Notably,
we detected only two strains containing the parCmutation; these
strains were from India, confirming our previous observation that
this mutation is rare and has only been identified in strains circu-
lating in India (15). There were 13 NALR isolates that tested neg-
ative for gyrA and parCmutations usingMLPA; direct sequencing
of the amplicons confirmed the MLPA data. We suggest that this
10% discrepancy between MLPA and NALR phenotypic data was
caused by either fluctuation in zone size readings during antimi-
crobial susceptibility testing by disk diffusion or by novel muta-
tions in the QRDR that were not represented in this assay (15).
The successful use ofMLPA to identify pointmutations is encour-
aging and suggests that this method can be adapted to establish a
simple and robust alternative to SNP typing for S. Typhi and other
monomorphic pathogens, which may be more phylogenetically
informative than the use of genomic indels.
The potential limitations of our work include the lack of an
incHI1 plasmid probe, a bias toward isolates from Vietnam, and
the fact that some indel profiles are shared by several genetically
diverse S. Typhi genotypes, while other indel profiles definemuch
more homogeneous groups. Hence, the resolution offered by in-
del typing is somewhat varied. We suggest that the discrepancies
between SNP and MLPA typing are induced by the stability of
some indels in different lineages, predicting that some indel loci
may not be as phylogenetically informative as others. However,
notwithstanding these limitations, our comparison of genome-
wide SNP with MLPA typing showed that MLPA was able to dis-
tinguish between five common S. Typhi isolates and, most signif-
icantly, was able to correctly identify H58 strains from Vietnam
and across Asia. Principally, we were able to distinguish H58
strains with and without gyrA mutations with 100% accuracy. It
has been shown that H58 strains currently predominate in the
majority of endemic locations, and there is an association between
H58 strains and S83F gyrAmutations and anMDR phenotype (3,
13). The MLPA data confirmed that H58 S. Typhi is dominant in
Vietnam and is widely dispersed across Asia, and it is associated
with both NALR and MDR in these regions. As the use of high-
resolution SNP typing and genome sequencing have previously
reported similar associations, the ability of MLPA to reproduce
this result confirms its reliability and potential utility for epidemi-
ological investigations. We advocate a new system for the subtyp-
ing of S. Typhi and propose that indel detection, either by MLPA
or conventional PCR, be adopted until SNP typing becomesmore
routine. We aim to develop a global Web-based S. Typhi, S. Para-
typhi A, invasive nontyphoidal Salmonella reference network
whereby serotyping is combinedwith simple genotyping informa-
tion, antimicrobial resistance profiling, and the time and date of
isolation. The use of a standardized kit-based assay, such as the
one presented here, that can be adapted through targeted genome
sequencing would allow for routine data sharing and a global re-
source for assessing international epidemiology and defining ap-
propriate measures for therapy and vaccination.
In conclusion, we have developed a simple, reliable, and epi-
demiologically relevant method that can be used in laboratories
with modest molecular biology equipment to subgroup S. Typhi
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and identify common NALR-associated mutations. This MLPA
method can distinguish between strains that currently dominate
the global population structure of S. Typhi, offering a more sen-
sitive and simple alternative to other subgrouping methodologies
that are currently being used in low- and middle-income coun-
tries.
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